Loading…
APYX
Apyx Medical Corp
NASDAQ· Healthcare· Medical Devices
$3.08+2.67%
Key metrics
- Market cap
- $129.74M
- P/E
- —
- Forward P/E
- —
- P/B
- 12.2x
- Dividend yield
- —
- EPS
- -$0.20
- ROE
- -90.69%
- Profit margin
- -14.78%
- Revenue growth
- +22.10%
- Beta
- 1.35
- 52-week high
- $5.08
- 52-week low
- $1.70
History
How the company evolved, year by year. Revenue and debt come from the annual statements; dividends from the payments themselves, which reach further back.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
About the company
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
- 205
- Clearwater, United States
Company description provided by Yahoo Finance.